BDF
ALXN

Balasa Dinverno & Foltz’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Balasa Dinverno & Foltz’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,405
Closed -$442K – 347
2021
Q2 		$442K Buy
2,405
+446
+23% +$82K 0.03% 202
2021
Q1 		$300K Buy
+1,959
New +$300K 0.02% 242